1-Edi-Osagie ECO; Seif MW; Aplin JD; Jones CJP; Wilson G. and Lieberman BA.

Characterizing the endometrium in unexplained and tubal factor infertility: a multiparametric investigation.

Fertil Steril. 2004;82(5):1379–1389.

2-Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; et al.

Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.

Fertil Steril. 2016; 106(2): 334-341.

3-Senturk LM. and Erel CT.

Thin endometrium in assisted reproductive technology.

Curr Opin Obstet Gynecol. 2008; 20(3): 221-228.

4-Amit A; Thaler I; Paz Y. and Itskovitz‐Eldor J.

The effect of a nitric oxide donor on Doppler flow velocity waveforms in the uterine artery during the first trimester of pregnancy.

J Int Soc Ultrasound Obstet Gynecol. 1998; 11(2): 94-98.

5-Cameron IT. and Campbell S.

Nitric oxide in the endometrium.

Hum Reprod Update. 1998; 4(5): 565-569.

6-Ballard SA; Gingell CJ; Tang Kim; Turner LA; Price ME. and Naylor AM.

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.

J Urol. 1998; 159(6): 2164-2171.

7-Keating GM. and Scott LJ.

Vardenafil. Drugs. 2003; 63(23): 2673-2702.

8-Tawfik MA; Tadros MI. and Mohamed MI.

Polyamidoamine (PAMAM) dendrimers as potential release modulators and oral bioavailability enhancers of vardenafil hydrochloride.

Pharm Dev Technol. 2019; 24(3): 293-302.

9-Klein S. and Tietz K.

Vaginal and Intrauterine Delivery Systems.

Vitr Drug Release Test Spec Dos Forms. 2019;177–209.

10-Rodrigues F; Maia MJ; das Neves J; Sarmento B; Amaral MH. and PP Oliveira MB.

Vaginal suppositories containing Lactobacillus acidophilus: development and characterization.

Drug Dev Ind Pharm. 2015; 41(9): 1518-1525.

11-Allen Jr L V. and Ansel HC.

Ansel’s pharmaceutical dosage forms and drug delivery systems/Loyd V. Allen; Jr.; Howard C.

Ansel. 2014.

12-Allen LV. and Loyd V.

Quality control of suppositories. Suppositories. 2007; 139-158.

13-Bankole Victor O. and Oladimeji Francis A.

Evaluation of the kinetics and mechanism of piroxicam release from lipophilic and hydrophilic suppository bases.

Int J ChemTech Res. 2017; 10: 189-198.

14-El-Majri MA. and Sharma RK.

Formulation and evaluation of piroxicam suppositories.

Int J Drug Deliv. 2010;2(2).

15-Choi H-G; Lee M-K; Kim M-H. and Kim C-K.

Effect of additives on the physicochemical properties of liquid suppository bases.

Int J Pharm. 1999; 190(1): 13-19.

16-Özgüney I. and Kardhiqi A.

Properties of bioadhesive ketoprofen liquid suppositories: preparation; determination of gelation temperature; viscosity studies and evaluation of mechanical properties using texture analyzer by 4× 4 factorial design.

Pharm Dev Technol. 2014; 19(8): 968-975.

17-Zawar LR. and Bhandari GS.

Formulation and evaluation of sustained release ondansetron poloxamer based solid suppositories.

J Appl Pharm Sci. 2012; 2(7): 186.

18-Adegboye TA. and Itiola IO.

Physical and release properties of metronidazole suppositories.

Trop J Pharm Res. 2008; 7(1): 887-896.

19-Setnikar I. and Fantelli S.

Liquefaction time of rectal suppositories.

J Pharm Sci. 1962; 51(6): 566-571.

20-Ceschel GC; Maffei P; Borgia SL; Ronchi C. and Rossi S.

Development of a mucoadhesive dosage form for vaginal administration.

Drug Dev Ind Pharm. 2001; 27(6): 541-547.

21-Kaewnopparat S. and Kaewnopparat N.

Formulation and evaluation of vaginal suppositories containing Lactobacillus.

World Acad Sci Eng Technol. 2009; 55: 25-28.

22-Zuheir A; Samein LH. and Aiash N.

Preparation and in vitro evaluation of metoclopramide HCL hollow-type suppository.

Int J Pharm Pharm Sci. 2013; 5: 660-666.

23-Abass H; Kamel R. and Abdelbary A.

Metronidazole bioadhesive vaginal suppositories: formulation; in vitro and in vivo evaluation.

Int J Pharm Pharm Sci. 2012; 4: 344-355.

24-Parikh KJ. and Sawant KK.

Solubilization of vardenafil HCl in lipid-based formulations enhances its oral bioavailability in vivo: a comparative study using Tween-20 and Cremophor-EL.

J Mol Liq. 2019; 277: 189-199.

25-Bilensoy E; Rouf MA; Vural I; Šen M. and Hincal AA.

Mucoadhesive; thermosensitive; prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex.

AAPS Pharm Sci Tech. 2006; 7(2): E54.

26-Chatterjee B; Amalina N; Sengupta P. and Mandal UK.

Mucoadhesive polymers and their mode of action: A recent update.

J Appl Pharm Sci. 2017; 7(5): 195-203.

27-Cheng C-L; Kang G-J. and Chou C-H.

Development and validation of a high-performance liquid chromatographic method using fluorescence detection for the determination of vardenafil in small volumes of rat plasma and bile.

J Chromatogr A. 2007; 1154 (1-2): 222-229.

28-Hanaee J; Javadzadeh Y; Taftachi S; Farid D. and Nokhodchi A.

The role of various surfactants on the release of salbutamol from suppositories.

Farm. 2004; 59(11): 903-906.

29-Yahagi R; Machida Y. and Onishi H.

Mucoadhesive suppositories of ramosetron hydrochloride utilizing Carbopol®.

Int J Pharm. 2000; 193(2): 205-212.